Ground Swell Capital’s CalciMedica CALC Stock Holding History

Ground Swell Capital’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,461	Closed	-$6.65K	–	158
2026 Q1	$6.65K	Buy	+2,461	New	+$25K	0.01%	107

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ground Swell Capital's CALC Position: Q2 2026 in Review

Ground Swell Capital sold out of CalciMedica (CALC) in Q2 2026, closing a stake of 2,461 shares — an estimated $6.65K sold.

Ground Swell Capital first reported a position in CALC in Q1 2026 and held it in 1 quarter. The position peaked at $6.65K in Q1 2026. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Ground Swell Capital reported no remaining CalciMedica position as of Q2 2026 after selling out during the quarter.
Ground Swell Capital sold 2,461 CalciMedica shares in Q2 2026, an estimated $6.65K.
Ground Swell Capital first reported a position in CalciMedica in Q1 2026 and held it in 1 quarter.
Ground Swell Capital's CalciMedica position peaked at $6.65K in Q1 2026.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.